Evidence map›Paper›PMID 24828130›Full record

Trial reportJournal of child and adolescent psychopharmacology2014

Aripiprazole decreases irritability in 12 out of 14 youth with autism spectrum disorders.

Ann Maloney, Eric O Mick, Jean Frazier

Open access · greenAbstract readClinical TrialLetter
In one paragraph

Trial report in Journal of child and adolescent psychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Aripiprazole for autism spectrum disorders (ASD).The Cochrane database of systematic reviews · 2016
    Pooled it
  2. Practitioner's review: medication for children and adolescents with autism spectrum disorder (ASD) and comorbid conditions.Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater · 2021
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ann MaloneyDepartment of Psychiatry, UMASS Medical School , Worcester, Massachusetts.
Eric O Mick
Jean Frazier
University of Massachusetts Chan Medical School · US

Funding

TISSUE CULTURE CORE FACILITYP30HD004147 · NICHD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CURTIN, CAROL · 1985 to 2014
$9.1M
NICHD NIH HHS P30HD004147
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAntipsychotic AgentsAripiprazoleChildChild Development Disorders, PervasiveFemaleHumansIrritable MoodMalePiperazinesQuinolonesTreatment OutcomeAntipsychotic AgentsAripiprazolePiperazinesQuinolones

Identifiers

PMID24828130
PMCPMC4137505
OpenAlexW1991338569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.